Stefano George B, Kream Richard M
MitoGenetics, LLC, Farmingdale, NY, USA.
Med Sci Monit. 2015 Dec 1;21:3736-9. doi: 10.12659/msm.895990.
The primacy of glucose derived from photosynthesis as an existential source of chemical energy across plant and animal phyla is universally accepted as a core principle in the biological sciences. In mammalian cells, initial processing of glucose to triose phosphate intermediates takes place within the cytosolic glycolytic pathway and terminates with temporal transport of reducing equivalents derived from pyruvate metabolism by membrane-associated respiratory complexes in the mitochondrial matrix. The intra-mitochondrial availability of molecular oxygen as the ultimate electron acceptor drives the evolutionary fashioned chemiosmotic production of ATP as a high-efficiency biological process. The mechanistic bases of carcinogenesis have demonstrated profound alteration of normative mitochondrial function, notably dysregulated respiratory processes. Accordingly, the classic Warburg effect functionally links aerobic glycolysis, aberrant production and release of lactate, and metabolic down-regulation of mitochondrial oxidative processes with the carcinogenetic phenotype. We surmise, however, that aerobic fermentation by cancer cells may also represent a developmental re-emergence of an evolutionarily conserved early phenotype, which was "sidelined" with the emergence of mitochondrial oxidative phosphorylation as a primary mechanism for ATP production in normal cells. Regardless of state-dependent physiological status in mixed populations of cancer cells, it has been established that mitochondria are functionally linked to the initiation of cancer and its progression. Biochemical, molecular, and physiological differences in cancer cell mitochondria, notably mtDNA heteroplasmy and allele-specific expression of selected nuclear genes, may represent major focal points for novel targeting and elimination of cancer cells in metastatic disease afflicting human populations. To date, and despite considerable research efforts, the practical realization of advanced mitochondrial targeted therapies has not been forthcoming.
光合作用产生的葡萄糖作为跨植物和动物门类的化学能量存在来源的首要地位,被普遍认为是生物科学中的一个核心原则。在哺乳动物细胞中,葡萄糖初步加工为磷酸丙糖中间体的过程发生在胞质糖酵解途径中,并随着线粒体基质中膜相关呼吸复合体对丙酮酸代谢产生的还原当量的暂时转运而终止。作为最终电子受体的分子氧在线粒体内的可用性驱动了进化形成的ATP化学渗透产生,这是一个高效的生物过程。致癌作用的机制基础已表明正常线粒体功能发生了深刻改变,尤其是呼吸过程失调。因此,经典的瓦伯格效应在功能上将有氧糖酵解、乳酸的异常产生和释放以及线粒体氧化过程的代谢下调与致癌表型联系起来。然而,我们推测癌细胞的有氧发酵也可能代表一种进化上保守的早期表型的发育性重新出现,这种表型在正常细胞中线粒体氧化磷酸化作为ATP产生的主要机制出现时被“边缘化”了。无论癌细胞混合群体中依赖状态的生理状态如何,线粒体在功能上与癌症的发生及其进展相关已得到证实。癌细胞线粒体中的生化、分子和生理差异,特别是线粒体DNA异质性和选定核基因的等位基因特异性表达,可能是在困扰人类的转移性疾病中靶向和消除癌细胞的新重点。迄今为止,尽管进行了大量研究工作,但先进的线粒体靶向治疗尚未实际实现。